Benlysta Approved in Europe for Lupus Nephritis
https://pixabay.com/photos/hospital-infusion-hand-association-834157/

Benlysta Approved in Europe for Lupus Nephritis

  In early May 2021, pharmaceutical company GlaxoSmithKline shared that its therapy Benlysta (belimumab) was approved by the European Commission (EC) for expanded use in adult patients with lupus nephritis…

Continue Reading Benlysta Approved in Europe for Lupus Nephritis
Cerebra Network for Neurodevelopmental Disorders: New Collaborative Research Network Investigates Rare Disorders
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

Cerebra Network for Neurodevelopmental Disorders: New Collaborative Research Network Investigates Rare Disorders

Rare disease research faces many obstacles: lack of participants, lack of funding, and lack of interest are just a few. Now, the charity Cerebra has launched a network to take…

Continue Reading Cerebra Network for Neurodevelopmental Disorders: New Collaborative Research Network Investigates Rare Disorders
Study Illuminates Impact of Aromatic L-Amino Acid Decarboxylase Deficiency on Caregivers
source: pixabay.com

Study Illuminates Impact of Aromatic L-Amino Acid Decarboxylase Deficiency on Caregivers

PTC Therapeutics has just announced data from the very first study which examined how taking care of a child diagnosed with aromatic L-amino acid decarboxylase (AADC) deficiency can impact caregivers.…

Continue Reading Study Illuminates Impact of Aromatic L-Amino Acid Decarboxylase Deficiency on Caregivers
The First Patient Has Been Dosed in a Trial for Glioblastoma, Medulloblastoma, and Ependymoma
source: pixabay.com

The First Patient Has Been Dosed in a Trial for Glioblastoma, Medulloblastoma, and Ependymoma

Mustang Bio, a biopharmaceutical company, and City of Hope, a cancer center, have just revealed that their first participant in their Phase 1 clinical trial for leptomeningeal brain tumors including…

Continue Reading The First Patient Has Been Dosed in a Trial for Glioblastoma, Medulloblastoma, and Ependymoma
Study Shows COVID-19 Long-Haulers Mimic Chronic Fatigue Syndrome Over Time
source: pixabay.com

Study Shows COVID-19 Long-Haulers Mimic Chronic Fatigue Syndrome Over Time

COVID-19 long-haulers, now called Post-Acute Sequelae of SARS-CoV-2 Infection, or PASC, have often been compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). However, there wasn't a study directly comparing these two…

Continue Reading Study Shows COVID-19 Long-Haulers Mimic Chronic Fatigue Syndrome Over Time
Webinar: Is This Multidisciplinary Approach the Future of Brain Tumor Treatment?
source: pixabay.com

Webinar: Is This Multidisciplinary Approach the Future of Brain Tumor Treatment?

According to a story from yahoo.finance.com, the medical technology company iCAD, Inc. recently held a webinar featuring several brain tumor experts that discussed the potential of an approach called intraoperative…

Continue Reading Webinar: Is This Multidisciplinary Approach the Future of Brain Tumor Treatment?
Woman with Immune Thrombocytopenia and COVID-19 Successfully Gives Birth
source: pixabay.com

Woman with Immune Thrombocytopenia and COVID-19 Successfully Gives Birth

According to a story from republicworld.com, the medical fraternity of Queen Mary's Hospital in King George's Medical University, Lucknow was able to successfully treat a woman, age 35, with immune…

Continue Reading Woman with Immune Thrombocytopenia and COVID-19 Successfully Gives Birth